ArticleDrug delivery2018

Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors.

Chia-Yu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.